Zobrazeno 1 - 10
of 592
pro vyhledávání: '"M, Di Bari"'
Autor:
F Verga, F Orso, C Salucci, G D‘Errico, E Perini, M Vatri, E Poletti, C Cagnoni, G Corti, M Di Bari, A Ungar, S Baldasseroni
Publikováno v:
European Heart Journal Supplements. 25:D72-D73
SGLT2–i have been shown to improve prognosis in patients with heart failure with reduced ejection fraction (HFrEF) in randomized clinical trials (RCTs). However, at the moment, we have little data on the use of these drugs in clinical practice, bot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d2b0fc6bb764ee5af03342215e9993e
https://doi.org/10.1093/eurheartjsupp/suad111.170
https://doi.org/10.1093/eurheartjsupp/suad111.170
Autor:
G D’Errico, F Orso, F Verga, C Salucci, E Perini, M Vatri, E Poletti, C Cagnoni, G Corti, M Di Bari, A Ungar, S Baldasseroni
Publikováno v:
European Heart Journal Supplements. 25:D174-D175
In July 2022 C.M., a 58–year–old woman, was admitted to our Heart Failure Outpatient Clinic. Patient with permanent AF undergoing DOAC therapy, previous double mitral and tricuspid valve replacement with bioprosthesis. As comorbidities she had st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::989d524138536248835af3970fd8cd15
https://doi.org/10.1093/eurheartjsupp/suad111.405
https://doi.org/10.1093/eurheartjsupp/suad111.405
Autor:
C Fumagalli, F Bonanni, M Beltrami, R Ruggiero, C Zocchi, L Tassetti, N Maurizi, M Zampieri, F Lovero, M Di Bari, N Marchionni, P Pieragnoli, F Cappelli, S Fumagalli, I Olivotto
Publikováno v:
European Heart Journal. 43
Background Patients with hypertrophic cardiomyopathy (HCM) are at increased risk of atrial fibrillation (AF) and stroke, especially at an advanced disease stage. To date, however, the incidence and factors associated with cardioembolic events in HCM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93bbc46f7a78a894bb58083e4728fb46
https://doi.org/10.1093/eurheartj/ehac544.1735
https://doi.org/10.1093/eurheartj/ehac544.1735
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
F Verga, F Orso, C Salucci, G D‘Errico, E Perini, M Vatri, E Poletti, C Cagnoni, G Corti, M Di Bari, A Ungar, S Baldasseroni
Publikováno v:
European Heart Journal Supplements. 25:D174-D174
Heart failure (HF), despite new therapeutic strategies, remains a condition characterized by an inauspicious prognosis and poor quality of life. The management of advanced and then terminal SC proves to be a current challenge, especially in elderly p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4484b5da2df1db74bf8136d64e182da2
https://doi.org/10.1093/eurheartjsupp/suad111.402
https://doi.org/10.1093/eurheartjsupp/suad111.402
Autor:
C Salucci, F Orso, F Verga, G D‘Errico, E Perini, C Cagnoni, E Poletti, M Vatri, G Corti, M Di Bari, A Ungar, S Baldasseroni
Publikováno v:
European Heart Journal Supplements. 25:D174-D174
Hyperkalimia (HK) is a condition that occurs very frequently in patients with heart failure (HF). HK often limits and discourages the implementation and optimization of RAASI therapy in patients with HFrEF. The introduction of the new K–binders dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0ddf5104c426a2845945863b790e97f
https://doi.org/10.1093/eurheartjsupp/suad111.403
https://doi.org/10.1093/eurheartjsupp/suad111.403
Autor:
G D‘Errico, A Herbst, F Orso, S Baldasseroni, F Fattirolli, S Virciglio, V Camartini, M Di Bari, N Marchionni, A Ungar, C Salucci, F Verga
Publikováno v:
European Heart Journal Supplements. 24
Background After the lockdown imposed by the COVID19 pandemic, physicians had to limite ambulatory visits to exceptional cases to reduce interpersonal contact. We structured a telephone follow–up developing a standardized 23 item questionnaire to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f10b4e2200bb89cbfa14b7a8508f773
https://doi.org/10.1093/eurheartj/suac012.242
https://doi.org/10.1093/eurheartj/suac012.242
Autor:
C Salucci, E Girardi, F Orso, A Herbst, M Migliorini, C Ghiara, S Virciglio, V Camartini, S Tognelli, G Fortini, M Di Bari, S Baldasseroni, A Ungar, N Marchionni, F Fattirolli
Publikováno v:
European Heart Journal Supplements. 24
Background Due to the total lockdown during COVID–19 pandemic, clinicians were forced to organize telephone visits or tele–monitoring. We developed a standardized multiparametric questionnaire, suitable for telephone administration to older heart
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6674f19c08b22ba2655032154f8293ca
https://doi.org/10.1093/eurheartj/suac012.240
https://doi.org/10.1093/eurheartj/suac012.240
Autor:
V Camartini, F Orso, A Herbst, S Virciglio, C Salucci, F Verga, G D‘Errico, M Di Bari, A Ungar, F Fattirolli, N Marchionni, S Baldasseroni
Publikováno v:
European Heart Journal Supplements. 24
Background The use of intermittent infusion of Levosimendan (L) demonstrated to be able to reduce hospitalisations and to improve functional capacity and quality of life in patients with advanced heart failure (HF). Purpose To describe our preliminar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e2c562ff6f97d3df9102b78d52ec320
https://doi.org/10.1093/eurheartj/suac012.251
https://doi.org/10.1093/eurheartj/suac012.251